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Abstract. 
Oropouche virus (OROV) is an important cause of arboviral illness in Latin American countries, more specifically 
in the Amazon region of Brazil, Venezuela and Peru, as well as in other countries such as Panama. In the past 
decades, the clinical, epidemiological, pathological, and molecular aspects of OROV have been published and 
provide the basis for a better understanding of this important human pathogen. Here, we describe the milestones in a 
comprehensive review of OROV epidemiology, pathogenesis, and molecular biology, including a description of the 
first isolation of the virus, the outbreaks during the past six decades, clinical aspects of OROV infection, diagnostic 
methods, genome and genetic traits, evolution, and viral dispersal. 
INTRODUCTION 
Oropouche virus (OROV) is one of the most common arboviruses that infect humans in 
Brazil. It is estimated that since the first isolation of the virus in 1955, it has affected more than 
half a million people. However, the exact number of cases is difficult to determine, because the 
infection is underreported due to the similarity of symptoms with other arboviral febrile illnesses, 
such as Dengue, Zika, Chikungunya, and Mayaro fevers. The lack of an exact diagnosis in 
hospitals and health-care centers hinders the proper epidemiological notification, which is the 
principal reason why the estimated number of cases is lower than what is probably occurring in 
the population, especially in the Amazon-endemic region. 
OROV is the causative agent of Oropouche fever, a febrile arboviral illness that is frequently 
associated with the Brazilian–Amazon region.1 The first case of OROV disease was described in 
Trinidad and Tobago in 1955: the virus was isolated from the blood of a febrile forest worker 
(strain TRVL 9760), a resident of a village called Vega de Oropouche, 3 miles north of Sangre 
Grande.
2
 Another strain of OROV was isolated from a pool of 177 Coquillettidia venezuelensis 
(Theobald) mosquitoes collected in Bush Bush Forest, Nariva Swamp, Trinidad, on October 18, 
1960. This second strain (TRVL 35111) was antigenically closely related to the prototype strain 
TRVL 9760 by complement fixation (CF) and neutralization (NT) tests.
2
 The virus was first 
isolated in Brazil in 1960 from the blood of a sloth, Bradypus trydactilus, captured in a forested 
area during the construction of the Belém-Brasilia highway and also from a pool of Ochlerotatus 
serratus mosquitoes caught near the same area.
3
 
In the following year, the virus was again detected in Belém City, the capital of Pará State, 
northern Brazil. On that occasion, a large epidemic of Oropouche fever was reported in Belém 
with an estimated 11,000 people affected.
4
 With that outbreak, OROV demonstrated its epidemic 
potential and many other outbreaks have been described subsequently in urban areas in the states 
of Acre, Amapá, Amazonas, Maranhão, Pará, Rondônia, and Tocantins, as well as other South 
American countries, such as Panama in 1989 and at the Amazon region of Peru between 1992 
and 1994.
1,5,6
 
More recently, OROV was reported in the municipalities of Parauapebas, Porto de Moz, 
Igarapé Açu, Magalhães Barata, and Maracanã, in Pará State, northern Brazil; the last three were 
located in the Bragantina area, the region where the virus was first detected in 1970.
7,8
 In 2009, 
the last OROV outbreak was reported in the municipalities of Altamira and Santa Barbara, Pará 
State, and subsequently in Mazagão in the state of Amapá, Brazil.
9
 
In this report, we review the past 60 years of OROV research, providing a brief overview of 
some of the key milestones that have been achieved since the original isolation of the virus 
(Figure 1). We also discuss some of the main current research directions and key goals for the 
future, with an emphasis on taxonomy, epidemiology, transmission cycles, evolution, and 
progress on the understanding of the pathogenesis. 
TAXONOMY AND CLASSIFICATION 
OROV is a member of the family Bunyaviridae, genus Orthobunyavirus, the largest genus of 
RNA viruses with over 170 named viruses corresponding to 18 different serogroups and 48 
species complexes.
10,11
 The OROV classification was originally made using serological methods, 
such as CF, hemagglutination inhibition (HI), or neutralizing (NT) tests.
12
 These methods have 
been used for grouping viruses by their antigenic relationship. OROV belongs to the Simbu 
serogroup, which includes 22 officially recognized viruses that have been grouped into seven 
different species complexes: Akabane, Manzanilla, Oropouche, Sathuperi, Simbu, Shamonda, 
and Shuni,
11
 as well as several other recently described viruses that have not yet been assigned to 
a species or serocomplex (Table 1). With the advent of molecular methods and next generation 
sequencing, full genomic sequences have been determined, improving the taxonomy of viruses, 
including members of the genus Orthobunyavirus.
13
 Currently, the Simbu serogroup is composed 
by two phylogenetic subclades: subclade A, which includes Oropouche and Manzanilla 
orthobunyaviruses, and subclade B, constituted by Simbu, Shuni, Shamonda, Sathuperi, and 
Akabane viruses.
14
 Hemagglutinin antigens can be prepared to OROV from brain and serum 
samples of infected hamsters, which have been used in epidemiological surveillance for precise 
serological diagnostic of OROV infections since 1985.
15,16
 
OROV replicates in numerous cell cultures, including C6/36, Vero, BHK-21, MA III, LCM-
MK2, and primary chicken embryo fibroblasts, causing a cytopathic effect from subtotal to total 
destruction of the cell monolayer, depending on the MOI used and time postinfection.
16
 OROV is 
sensitive to sodium deoxycholate, which reduces the ability of the virus to infect the host cells by 
destroying the envelope glycoprotein, a viral structure that is directly associated with virus–host 
interaction.
14,17,18
 
VIRAL STRUCTURE, GENOME, AND REPLICATIVE CYCLE 
Although no specific ultrastructural studies of OROV in human tissues have been published 
to date, it is probable that this viral agent exhibits particles with similar morphological 
characteristics to other members of the Orthobunyavirus genus. Ultrastructural studies of La 
Crosse virus have shown that virus particles are spherical, measuring between 80 and 110 nm in 
diameter, surrounded by a lipid envelope.
19
 Internally, the viral particle contains three single-
stranded negative sense segments of genomic RNA of different sizes that are individually 
connected to the L protein (viral RNA-dependent RNA polymerase) and which are surrounded 
by the nucleocapsid (N) protein, forming three ribonucleoproteins.
20
 
The genomic segments are named small (SRNA), medium (MRNA), and large (LRNA), 
according to their respective molecular sizes. The partial viral genome for the Brazilian 
prototype OROV strain BeAN 19991 was sequenced, and recently the complete genomic 
sequences for the three segments, including the full noncoding regions (NCRs) was described, 
showing a SRNA segment of 958 nucleotides, a MRNA with 4,385 nucleotides and a LRNA 
with 6,852 nucleotides in length (Figure 2).
21–23
 The coding sequences of the three genomic 
segments are flanked by two terminal NCRs namely 5 and 3 NCRs, that have different number 
of nucleotides in length, but have eleven nucleotides that are highly conserved between the three 
RNA segments. These regions are complementary to each other in a typical arrangement that 
provides a circularization in the genomic RNA that is essential for the activity of this region as 
replication and transcription promoters, as indicated recently in a minigenome system assay that 
introduced mutations in the NCRs.
22
 
The LRNA contains one open reading frame (ORF) that encodes the L protein, an RNA-
dependent RNA polymerase. The L protein has a molecular weight of 261.25 kDa and is 
associated to the three viral RNA segments.
24
 The MRNA contains a single ORF that encodes a 
large polyprotein that is cleaved after or during translation, yielding three viral proteins, two 
structural surface glycoproteins: Gn (28.03 kDa) and Gc (107.14 kDa) and a nonstructural 
protein named NSm (26.65 kDa).
11
 The SRNA segment encodes a structural nucleocapsid 
protein (26.26 kDa) and a nonstructural NSs protein (10.65 kDa), in two overlapping ORFs. 
Recently, the rescue of recombinant OROV viruses by reverse genetics lacking these 
nonstructural proteins demonstrated that NSm is dispensable for virus replication in mammalian 
and mosquito cells, whereas NSs is an important virulence gene, acting as a type I interferon 
(IFN) antagonist.
25
 
The details of the OROV replication cycle are still unknown. Progeny production is observed 
10 hours postinoculation of the virus in HeLa cells, with a peak after 24 hours.
26
 The interaction 
between the virus particle and the cell receptor is most likely mediated by the surface 
glycoproteins Gn and Gc, and the virus enters HeLa cells by endocytosis mediated by clathrin-
coated vesicles, whereas the release of viral particles from the endosome is dependent on 
endosomal acidification.
26
 
One important cytopathic effect observed after OROV replication in HeLa cells is the 
induction of apoptosis, which was detected at 36 hours postinfection.
26
 Release of cytochrome c 
and activation of caspases 9 and 3 were detected, and apoptosis occurs without affecting the viral 
load, indicating that it might be important during the replication cycle of OROV. The same work 
suggested that viral protein synthesis is necessary for the induction of apoptosis, indicating that 
one or more viral proteins might be involved in this mechanism. 
GEOGRAPHICAL DISTRIBUTION OF OROV 
Thus far, the only reported cases of Oropouche (ORO) fever have occurred in Brazil, 
Panama, Peru, and Trinidad and Tobago. In Brazil, since the first isolation of the virus in 1955 
until 1980, OROV caused several epidemics apparently restricted to the State of Pará, northern 
Brazil, reaching different municipalities of distinct mesoregions: metropolitan area of Belém 
(municipalities of Belém, Ananindeua, Benfica, Caraparu, Castanhal, and Santa Isabel); 
northeast (Abaetetuba, Augusto Correia, Baião, Bragança, Capanema, Curuçá, Tomé-Açu, Vigia, 
and Viseu); southeast (Itupiranga); lower Amazon (Belterra, Mojuí dos Campos, and Santarém); 
and Marajó Island (Porto de Moz). During this period, only the southwest mesoregion did not 
report cases or ORO fever.
4,27–30
 
Between 1981 and 1996, outbreaks of ORO fever were registered in the state of Pará 
(Oriximiná, mesoregion low Amazon; Brazil Novo and Altamira, mesoregion southeast); as well 
as in other states, such as in the cities of Manaus, Novo Airão, and Barcelos (Amazonas State), 
Mazagão (Amapá State), Xapuri (Acre State), Ariquemes, Machadinho, and Ouro Preto d’Oeste 
(Rondônia State), Porto Franco and Estreito (Maranhão State), and Tocantinópolis (Tocantins 
State).
1,15,16
 In 2000 and 2010, the virus was isolated from sylvatic monkeys (Callithrix 
penicillata) on two different occasions in Minas Gerais State, southeast Brazil.
22,31
 
In 2003 and 2004, outbreaks of ORO fever were detected in the municipalities of 
Parauapebas, Pará State (mesoregion east) and Porto de Moz (middle region of the lower 
Amazon), respectively.
7
 In 2006, additional OROV epidemics were registered in Pará State, in 
the cities of Maracanã, Igarapé-Açu, Magalhães Barata, and Viseu located in Bragantina area of 
northeast Pará, demonstrating the reemergence of the virus after 26 years of epidemiological 
silence in the region.
8
 In 2009, OROV reemerged in Pará State, more specifically in the 
municipalities of Santa Bárbara (metropolitan region of Belém), Altamira (mesoregion 
southeast), and in Mazagão, state of Amapá.
9
 
Outside of Brazil, epidemics have been reported in Panama and Peru. The outbreak in 
Panama was recorded in 1989 in the Village of Bejuco, located approximately 50 km west of 
Panama City, capital of the country. In Peru, ORO fever was documented in 1992, when the 
virus caused an outbreak in Iquitos City.
5,6
 Furthermore, two other outbreaks of OROV were 
recorded in the Peruvian Amazon in 1994, in the cities of Puerto Maldonado and Madre de 
Dios.
32
 
EPIDEMIC DISPERSION AND SEASONAL DISTRIBUTION 
ORO fever cases have been reported in different locations in a large geographical area, 
including both in South and Central Americas. During outbreaks, a representative epidemic 
dispersion process is observed, with transmission to several locations situated close to the region 
where the virus was first detected. This phenomenon was observed in outbreaks that occurred in 
several municipalities in the states of Pará and Rondônia, Brazil.
7,8
 The dispersal pattern of the 
virus is probably related to the movement of infected viremic people to locations where the 
potential urban vector Culicoides paraensis can be found.
3
 
ORO fever occurs predominantly in the rainy season, due to the increase in the breeding sites 
of the vector population. In Brazil, more specifically in the Brazilian Amazon region, the dry 
season corresponds to the months from July to December, whereas the rainy season occurs 
between January and June.
3
 Although less often, some OROV epidemics have been reported 
during the dry season, probably due to the high population density of Culicoides paraensis 
during previous rainy period. Furthermore, the occurrence of outbreaks is also related to the 
increase of susceptible human population not previously exposed to the virus. In general, 
decreasing of outbreaks is associated with the beginning of the dry season and the decreasing of 
midge density.
16
 
TRANSMISSION CYCLES 
Studies conducted by the Evandro Chagas Institute suggest that OROV is maintained in 
nature by two distinct cycles: sylvatic and urban (Figure 3).
33
 In the sylvatic cycle, there is 
evidence that pale-throated sloths (Bradypus tridactylus), nonhuman primates and some wild 
birds play a role as vertebrate hosts.
16,22,31
 
The vector of OROV in the forest is still unclear. On two occasions, the agent has been 
isolated from sylvatic mosquitoes, both in 1960. One isolation was from O. serratus collected in 
the Amazon region of Brazil, and the second was from Coquilletidia venezuelensis in 
Trinidad.
3,16
 
In the urban or epidemic cycle, humans apparently are the only vertebrates involved, since 
studies with domestic animals (e.g., dogs, cats, and chickens) excluded the role of these animals 
in the maintenance of the urban cycle.
16
 Humans are probably also the link between the sylvatic 
and urban cycles, when humans invade the forest, become infected, and return to urban areas 
during the viremic period.
16
 Two vectors are commonly found in urban epidemics: the biting 
midge Culicoides paraensis (Ceratopogonidae), regionally named as “maruim,” and the 
mosquito Culex p. quinquefasciatus (Culicidae). In laboratory experiments with the Culex p. 
quinquefasciatus, the insect proved to be an inefficient vector of OROV.
34
 Furthermore, Cardoso 
and others detected the SRNA of OROV in patients and in Culex quinquefasciatus, reinforcing 
the probable participation of Culex mosquitoes in the urban cycle of OROV.
35
 
The involvement of the biting midge as a vector of OROV is based on experimental studies 
carried out by Pinheiro and others.
16
 The authors demonstrated the ability of Culicoides 
paraensis to transmit the virus to hamsters after five or more days feeding on blood of viremic 
patients. These midges have diurnal activity, especially during the twilight period, and are 
aggressive bitters that are attracted by humans. Culicoides paraensis, small insect, is widely 
distributed in tropical and subtropical areas of the Americas, and is usually found in high density 
during epidemic periods. The larvae feed on decomposing organic materials, such as trunks of 
banana trees (genus Musa), fruits husks of coconut (Cocos nucifera), and Cupuaçu (Theobroma 
grandiflorum) trees, as well as in accumulated debris of trees.
36
 
However, the low isolation rate of the virus from Culicoides paraensis during epidemics is 
an intriguing problem. Further studies are necessary to determine if this phenomenon is due to 
the low susceptibility of the insect to OROV, or if only a small fraction of Culicoides paraensis 
population has the ability to transmit the virus.
37
 
INCUBATION AND TRANSMISSION PERIODS 
There is no precise information about the incubation period of ORO fever; however, some 
observations made during major epidemics suggest that it may vary from 4 to 8 days. In 1981, 
Pinheiro and others described two laboratory technicians who were accidentally infected with 
OROV, and showed ORO fever symptoms 3–4 days after infection.16 Although the report does 
not mention the conditions in which the virus was being manipulated, the transmission is thought 
to have occurred through the respiratory route.
16
 
The patient’s blood in the acute phase of the illness is infective to the Culicoides paraensis 
for the first 3–4 days from the onset of symptoms, when viremia is high enough to infect biting 
midges. Experimental studies in hamsters (Mesocricetus auratus) demonstrated that the extrinsic 
incubation period is five or more days.
38,39
 No evidence of direct transmission of OROV from 
one person to another has been reported.
33
 
INCIDENCE 
In general, the estimated incidence rates for OROV infection have been determined by 
seroepidemiological surveys, where groups of families were randomly selected. In this case, a 
clinical–epidemiological survey was applied to members of each family, and blood samples were 
collected for virus isolation (acute phase) in newborn mice (2–3 days old) and Vero cells, as well 
as for the detection of NT, CF, HI, and IgM antibodies (convalescent phase).
3,30
 
Although the incidence values have not been determined in some outbreaks, a relevant 
feature of ORO fever is related to a large number of OROV infections reported in all epidemic 
episodes described so far. Based on official records, the overall cases of ORO fever were 
estimated at 380,000 cases during the period from 1961 to 2007. It is important to note that in 
several outbreaks the uniformity in the numerical distribution of cases, as well as in the estimated 
incidence of cases was not homogeneous. Indeed, the average incidence rate was estimated as 
30%. In one of the described epidemics, the proportion of infected individuals showing clinical 
symptoms of OROV infection reached 63%.
28
 
Regarding gender, rates of OROV infections are quite varied. In 1979, during the outbreak in 
the Bragantina area, northeastern Pará State, females were the most infected group. On the other 
hand, in the same year, another outbreak occurred in Belém City, where males were the most 
affected.
16
 In an outbreak reported in Santarém City, Pará State, northern Brazil, the proportion 
of infected women was twice as high as the male population. In addition, ORO fever affects all 
age groups, although in some outbreaks, the incidence was greater in children and young 
adults.
3,27
 
MOLECULAR EPIDEMIOLOGY 
The first genetic study carried out with OROV was described by Saeed and coworkers in 
2000 and introduced the basis for understanding the molecular epidemiology of this viral agent. 
It suggested the existence of at least three distinct circulating genetic lineages in the Americas: 
genotypes I, II, and III.
40
 Based on findings from the nucleotide sequences obtained from the N 
gene of 28 OROV strains isolated from different hosts, geographical locations, and different 
periods of time, it was reported that genotype I was only detected in Trinidad and Tobago, 
whereas genotype II was restricted to Peru, and genotype III was found in Panama only. In 
Brazil, only genotypes I and II were detected: genotype I was more often found in eastern 
Amazon, whereas genotype II in western Amazon region.
40
 
In 2000, a strain of OROV was isolated from a new vertebrate host (Callithrix sp.) in the 
municipality of Arinos, Minas Gerais State, southeastern Brazil, and this isolate was classified as 
genotype III, previously found only in Panama. This finding reinforced the hypothesis that 
OROV has encountered favorable ecological conditions to allow its spread to other regions 
outside the original epidemiological area in the Amazon region. Furthermore, this also opened 
the possibilities for the virus to spread into highly susceptible populations that were residing in 
these urban areas, increasing the risk of outbreaks.
31,41
 
Molecular analysis of additional strains isolated during epidemics that occurred between 
2003 and 2006 in the municipalities of Parauapebas, Porto de Moz, Igarapé Açu, Maracanã, 
Magalhães Barata, and Viseu in the Bragantina region (Pará State) demonstrated the co-
circulation of genotypes I and II and their association with ORO fever cases.
7,8
 However, these 
results have to be treated with caution as the authors used only partial genetic information from 
each gene and not complete sequences. 
In the present study, the appearance of a fourth genotype, based on information obtained 
from genetic data for the SRNA segment was observed. This new phylogenetic group, isolated 
from humans during an outbreak in Manaus in the 1980s, was called genotype IV.
9
 Therefore, 
based on 111 complete coding sequences of the SRNA, it was possible to subdivide OROV into 
four genotypes and eight subgenotypes. Currently, the geographical distribution of OROV is 
described as follows: genotype I in Trinidad and Tobago and Brazil; genotype II in Panama, 
Peru, and Brazil; genotype III detected in Brazil and Peru, and the new genotype IV isolated only 
in Brazil (Figure 4). 
TIME-SCALED ANALYSIS AND PHYLOGEOGRAPHY OF OROV GENOTYPES 
Chronological analyses were conducted to investigate the emergence period of OROV in the 
Americas.
9
 We also determined the nucleotide substitution rate, based on 96 OROV N gene 
sequences (3.7 × 10
4
 substitutions per site per year), and we used this information to calculate 
the divergence dates among the strains. The most recent common ancestor for OROV in the 
Americas was estimated to have emerged around 223 years ago (95% highest probability density 
[HPD]: 148–342 years) generating the four different genotypes (I, II, III, and IV) that are 
currently described. Detailed analyses suggest that genotype I was the ancient genotype 
emerging ~112 years ago (95% HPD: 95–189 years), whereas genotype II subsequently emerged 
~91 years ago (95% HPD: 59–144 years) and was probably originated from strains isolated in 
the states of Pará and Rondônia, as well as from strains recently isolated in the Amapá State, in 
2009. Genotype IV emerged in the Amazonas State ~43 years ago (95% HPD: 31–56 years) and 
genotype III was considered the latest lineage to emerge in Brazil, about 37 years ago (95% 
HPD: 33–70 years) probably in the Rondonia State 33 years ago (95% HPD: 29–58 years), and 
in other states from Amazon region (e.g., Acre and Pará States), and emerging almost 
simultaneously in Panama about 32 years ago (95% HPD: 22–45 years) and, more recently, in 
Minas Gerais State, out of the official endemic area of OROV transmission (Figure 5). 
Based on results obtained for the N gene data by time-scaled analysis (evolutionary rate and 
emergence date) and epidemiologic data association (date and geographic location of isolation), 
the possible dispersal event could be predicted for the distinct OROV genotypes in the Americas. 
Genotype I (originally isolated in Brazil in the municipality of Ipixuna, Pará State, BR 010 
Highway, km 94), possibly spread continuously toward distinct regions: initially to several 
municipalities in western Pará State, and almost simultaneously in Trinidad and Tobago. Later, 
genotype I moved toward the states of Amazonas and Acre and finally to the eastern Amazon 
region including Pará, Maranhão, and Tocantins States. Genotype II apparently emerged 
simultaneously in the states of Amapá, Pará, and Rondônia, as well as in Peru, and dispersed in 
these places, emerging in the municipality of Mazagão, Amapá State, in 2009. Genotype III 
emerged in Rondônia State, moving toward Panama and the states of Acre and Maranhão in 
Brazil, and lately to Minas Gerais State. Genotype IV, apparently more ancient than genotype III, 
emerged in the city of Manaus, Amazonas State, and apparently is still restricted to that area. 
GENOMIC REASSORTMENT: MECHANISM OF VIRUS EVOLUTION 
Genomic reassortment is considered to be one of the most important mechanisms for the 
generation of viral biodiversity in orthobunyaviruses. This phenomenon can occur when two 
genetically related viruses infect the same susceptible cell at the same time, and the progeny 
virus can be formed containing a varied mixture of genomic L, M, and S segments from the two 
parental viruses. This phenomenon, which is also common with segmented viruses from other 
families, can have significant implications due to the possibility of the emergence of a virus with 
increased pathogenicity. The exchange of genomic RNA segments involving OROV have been 
reported in isolates obtained from Peru, Venezuela, and Brazil. The first reassortment event was 
reported in Peru when the Iquitos virus (IQTV) was isolated in 1999 from a febrile patient.
42
 
Further genome characterization of Simbu group viruses identified in 2007, also in Peru, the 
presence of another OROV reassortant associated to human disease, namely Madre de Dios virus 
(MDDV).
41
 Also, the MDDV was reported in a monkey (Cebus olivaceus Schomburgk) in a 
forest near Atapirire, a small rural village located in Anzoategui State, Venezuela.
43
 In 2015, 
Tilston-Lunel and others (2015) described the presence of Perdões virus (PERDV), a new OROV 
reassortant species isolated from the viscera of a nonhuman primate (Callithrix sp.) found dead 
in Minas Gerais State, Brazil.
22
 All reassortant species showed both SRNA and LRNA related to 
OROV, whereas the MRNA of IQTV probably is from MDDV, whereas the MRNAs of MDDV 
and PERDV remain unknown yet and are probably unique to its species (Figure 6). It is 
interesting to notice that in reassortment events, usually the S and L segments are those that are 
exchanged between species.
16
 It is known that the nucleocapsid protein coded by the S segment 
and the L polymerase function as a pair to replicate the viral genome. Therefore, one segment 
restricts the molecular evolution of the other, and is thought to be inherited as a pair. On the 
other hand, the M segment, which codes for the viral glycoproteins, could be more subjected to 
mutations due to the higher selective pressure on its coding region, since these proteins are the 
major host range determinants. The hypothesis that a different rate of mutation in the M segment 
compared with both L and S has also been suggested by Tilston-Lunel and others,
25
 which could 
also explain the molecular differences observed in the M segment of the reassortant viruses. 
CLINICAL ASPECTS 
Infections in humans caused by OROV are characterized as an acute febrile illness, usually 
accompanied by headache, myalgia, arthralgia, anorexia, dizziness, chills, and photophobia 
(Figure 3). Some patients present a rash that resembles rubella and nausea, vomiting, diarrhea, 
conjunctive congestion, epigastric pain and retro–orbital pain, and other systemic manifestations 
have also been described.
16
 A few days after the initial febrile episode, a recurrence of symptoms 
is commonly observed, but usually with less intensity, representing approximately 60% of cases. 
Some patients may display a clinical presentation of meningitis.
44
 Convalescence is complete 
without apparent sequel, even in severe cases. There is no fatality record demonstrably related to 
Oropouche fever.
3,44
 However, identification of OROV SRNA genomic segment in cerebrospinal 
fluid in patients from Amazonas State, northern Brazil, suggests that severe disease committing 
the central nervous system (CNS) is occurring during outbreaks of this virus in Brazil.
45
 
PATHOGENESIS 
Since fatalities have not been recorded, little is known about the pathogenesis of natural 
OROV infections. Humans present systemic symptoms, with viremia detected in the initial 2–4 
days of the onset of the first symptoms. In some patients, the virus has been recovered from the 
cerebrospinal fluid, but the route of invasion of the CNS is unknown.
46
 
Studies using experimental animal models have helped to elucidate some aspects of the 
pathogenesis of OROV. In 1978, Araujo and others demonstrated that viruses could be detected 
in liver lesions with significant necrosis of hepatocytes and considerable hypertrophy of Kupffer 
cells 6 hours after OROV was inoculated intracerebrally into 3-week-old hamsters, suggesting a 
hematogenous transmission of the virus from the brain to the liver.
39
 
A more detailed infection model in hamsters using viruses inoculated subcutaneously 
demonstrated the occurrence of systemic infection, with high viral load in the plasma, that can 
reach a peak of 10
6.0
 TCID50/mL at the 3rd day after infection.
39,47
 In this model, both brain and 
liver tissues demonstrated histological lesions, with the detection of viruses in high titers, and 
positive immunohistochemistry showing the presence of viral antigens in neurons.
47,48
 
The pathogenesis of OROV was also studied in murine models. BALB/c neonate mice 
inoculated subcutaneously presented clinical signs at the 5th day after inoculation. The animals 
presented a high concentration of replicating virus in the brain, with inflammation of the 
meninges and apoptosis of neurons, apparently without encephalitis.
47
 These data confirmed the 
neurotropism of this virus, as observed in the hamster model. The access to the CNS was 
revealed by immunohistochemistry, which showed that OROV infection advances from the 
posterior parts of the brain toward the forebrain. OROV reaches the neural routes during the 
early phases of infection, reaching the spinal cord and ascending to the brain through brainstem 
regions, with little inflammation. During the later periods of the infective cycle the virus crosses 
the blood–brain barrier, spreading into the brain parenchyma, with more severe manifestations of 
encephalitis.
47
 
Studies based on subcutaneous inoculations of OROV in wild type and mutated 
immunocompromised C57BL/6 mice revealed that induction of type I IFN pathway through 
MAVS, IRF-3, IRF-7, and IFNAR is essential to control OROV infection, and this likely occurs 
dominantly in nonmyeloid cells.
49
 In addition, the IRF-5 is a key component of the immune 
response against orthobunyaviruses and has a role in modulating the antiviral response in 
peripheral tissues, while contributing to inhibit the neuroinvasion process.
50
 
LABORATORIAL DIAGNOSIS 
Diagnosis of OROV infection is basically made using classic and molecular virology 
techniques: 1) virus isolation attempt in newborn mice and cell culture (Vero cells); 2) serologic 
assays, such as HI, NT, CF tests, and in-house-enzyme linked immunosorbent assay for total 
immunoglobulin, IgM and IgG detection, respectively, in convalescent sera; 3) reverse 
transcription polymerase chain reaction (RT-PCR) and real-time RT-PCR for genome detection 
in acute samples (sera, blood, and viscera of infected animals).
23,51,52
 In the latter case, the 
molecular methods were designed for specific detection of SRNA genome fragments. However, 
due to the existence of OROV reassortant events (e.g., MDDV, IQTV, and PERDV), new 
approaches based on the MRNA segment of OROV, which is unique to this virus, is needed to 
detect specifically infections caused by this important human pathogen. 
In 2001, Saeed and others engineered the first nucleocapsid recombinant protein antigen 
using a plasmidial Escherichia coli bacterial system. This antigen was tested in IgM enzyme-
linked immunosorbent assay (ELISA) assay in clinical samples from patients infected by the 
OROV in Brazil and Peru.
51
 Unfortunately, there are no available commercial diagnostic or rapid 
tests based on immunoassays (e.g., ELISA, immunochromatography). 
FUTURE PERSPECTIVES 
OROV is one of the most important orthobunyaviruses associated with human diseases in 
tropical America, with more than 30 major outbreaks and half million reported cases since its 
first isolation in 1955. In this review, we discussed the major breakthroughs achieved in OROV 
research. However, there are many more questions that need to be addressed to fully understand 
the epidemiology and pathogenesis of this virus. The reverse genetics system developed for 
OROV
25
 could be exploited for this purpose, which could be used to better understand the role of 
the nonstructural proteins during viral replication in mosquito and mammalian cells. This reverse 
genetics system could also be used to better understand the reassortment events in the family 
Bunyaviridae and its effects. Since the M segment is the only viral genomic segment that is 
different between MMDV, IQTV, and PERDV reassortants, the system could be used to generate 
recombinant viruses and study the differences they present in terms of pathogenesis, virulence 
outcome, and host range, which could elucidate important implications on the understanding of 
the evolution of orthobunyaviruses in South America. The virus-like particles assay developed 
for this virus
21,25
 could also be used as a tool to generate a potential recombinant vaccine as well 
as a safe BSL-3 free ELISA diagnosis, which could facilitate the study of the prevalence of 
OROV in South America. 
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FIGURE 1. Time line of advances in Oropouche virus research. This figure appears in color at www.ajtmh.org. 
FIGURE 2. Schematic representation of (A) genomic organization and (B) topology of glycoprotein of Oropouche 
virus strain BeAn 19991. This figure appears in color at www.ajtmh.org. 
FIGURE 3. Transmission cycles of Oropouche virus. 
FIGURE 4. Distribution of genotypes of Oropouche virus in Latin America based on 114 sequences of N gene. This 
figure appears in color at www.ajtmh.org. 
FIGURE 5. Phylogenetic tree based on the complete nucleotide sequence of the N gene of 114 Oropouche virus 
strains isolated from different hosts, locations, and periods. The main phylogenetic groups are represented by 
genotypes in color and subgenotypes in left bars. The values above the main nodes represent the dates of emergence 
of common ancestors, expressed in years before 2012. The arrows indicate the probable date of emergence of 
genotypes I, II, III, and IV. Numbers in parentheses are value for 95% highest probability density. This figure 
appears in color at www.ajtmh.org. 
FIGURE 6. Maximum likelihood phylogenetic analysis of subclade A: Simbu serogroup showing evidences of 
different tree topologies suggestive of genetic reassortment between Oropouche virus (OROV). In the above panel, 
the branches are highlighted according to the species recognized by the ICTV, ORO species in blue and Manzanila 
species in green, and taxon names in red indicates the reassortment events. The below panel illustrates the genetic 
pattern for the reassortment events involving Iquitos virus (IQTV), Madre de Dios virus (MDDV), and Perdões virus 
(PERDV) This figure appears in color at www.ajtmh.org. 
TABLE 1 
Distribution and classification of members of the Simbu serogroup according to the species, virus, geographic 
distribution, and year of isolation 
Species Virus Distribution Isolated from (year) 
Akabane Akabane virus Africa, Asia, Australia Cattle (1974) 
Akabane Sabo virus Africa Goat (1966) 
Akabane Tinaroo virus Australia Midges (1978) 
Akabane Yaba-7 virus Africa Mosquitoes (1963) 
Manzanilla Buttonwillow virus North America Rabbits (1962) 
Manzanilla Ingwavuma virus Africa, Asia Birds (1959) 
Manzanilla Inini virus South America Birds (1973) 
Manzanilla Manzanilla virus South America Monkey (1954) 
Manzanilla Mermet virus North America Monkey (1964) 
Oropouche  acey’s  addock virus Australia Mosquitoes (1974) 
Oropouche Jatobal virus South America Coati (1985) 
Oropouche Oropouche virus South America Human (1955) 
Oropouche Utinga virus South America Sloth (1965) 
Oropouche Utive virus South America Sloth (1975) 
Sathuperi Douglas virus Australia Cattle (1978) 
Sathuperi Sathuperi virus Africa, Asia Mosquitoes (1957) 
Sathuperi Schmallenberg virus Europe Cattle (2011) 
Shamonda Peaton virus Australia Midges (1976) 
Shamonda Sango virus Africa Cattle (1965) 
Shamonda Shamonda virus Africa Cattle (1965) 
Shuni Aino virus Asia, Australia Mosquitoes (1964) 
Shuni Kaikalur virus Asia Mosquitoes (1971) 
Shuni Shuni virus Africa Cattle (1966) 
Simbu Simbu virus Africa Mosquitoes (1955) 
Thimiri Thimiri virus Africa, Asia Birds (1963) 
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